Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
The American journal of gastroenterology • Vol. 103, Issue 10 • 2008
Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
Journal of pharmaceutical and biomedical analysis • Vol. 38, Issue 3 • 2005
Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
Neuropharmacology • Vol. 48, Issue 6 • 2005
Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain.
Psychopharmacology • Vol. 167, Issue 1 • 2003
